Cypress Capital Management (Wyoming)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-182
| Closed | -$4.53K | – | 216 |
|
|
2025
Q4 | $4.53K | Buy |
+182
| New | +$4.59K | ﹤0.01% | 152 |
|
|
2024
Q2 | – | Sell |
-100
| Closed | -$2.77K | – | 173 |
|
|
2024
Q1 | $2.77K | Buy |
+100
| New | +$2.77K | ﹤0.01% | 134 |
|
|
2023
Q4 | – | Sell |
-849
| Closed | -$28.2K | – | 180 |
|
|
2023
Q3 | $28.2K | Hold |
849
| – | – | 0.03% | 82 |
|
|
2023
Q2 | $31.1K | Hold |
849
| – | – | 0.03% | 78 |
|
|
2023
Q1 | $34.6K | Hold |
849
| – | – | 0.04% | 77 |
|
|
2022
Q4 | $43.5K | Hold |
849
| – | – | 0.05% | 73 |
|
|
2022
Q3 | $37K | Hold |
849
| – | – | 0.05% | 74 |
|
|
2022
Q2 | $45K | Hold |
849
| – | – | 0.06% | 72 |
|
|
2022
Q1 | $44K | Sell |
849
-21,170
| -96% | -$1.1M | 0.05% | 85 |
|
|
2021
Q4 | $1.3M | Sell |
22,019
-416
| -2% | -$20.6K | 1.09% | 30 |
|
|
2021
Q3 | $965K | Sell |
22,435
-163
| -0.7% | -$7.22K | 0.8% | 39 |
|
|
2021
Q2 | $885K | Buy |
22,598
+20,649
| +1,059% | +$803K | 0.68% | 42 |
|
|
2021
Q1 | $71K | Buy |
1,949
+1,100
| +130% | +$39.1K | 0.06% | 112 |
|
|
2020
Q4 | $31K | Sell |
849
-46
| -5% | -$1.69K | 0.03% | 137 |
|
|
2020
Q3 | $31K | Hold |
895
| – | – | 0.03% | 121 |
|
|
2020
Q2 | $28K | Hold |
895
| – | – | 0.03% | 123 |
|
|
2020
Q1 | $28K | Sell |
895
-1,054
| -54% | -$35.9K | 0.04% | 102 |
|
|
2019
Q4 | $72K | Hold |
1,949
| – | – | 0.07% | 99 |
|
|
2019
Q3 | $66K | Hold |
1,949
| – | – | 0.08% | 93 |
|
|
2019
Q2 | $80K | Sell |
1,949
-301
| -13% | -$12K | 0.1% | 95 |
|
|
2019
Q1 | $91K | Buy |
2,250
+94
| +4% | +$3.77K | 0.12% | 86 |
|
|
2018
Q4 | $89K | Sell |
2,156
-160
| -7% | -$6.64K | 0.17% | 88 |
|
|
2018
Q3 | $97K | Hold |
2,316
| – | – | 0.1% | 126 |
|
|
2018
Q2 | $80K | Hold |
2,316
| – | – | 0.08% | 133 |
|
|
2018
Q1 | $78K | Sell |
2,316
-1,603
| -41% | -$55.1K | 0.09% | 127 |
|
|
2017
Q4 | $135K | Sell |
3,919
-4,901
| -56% | -$167K | 0.15% | 102 |
|
|
2017
Q3 | $299K | Hold |
8,820
| – | – | 0.35% | 66 |
|
|
2017
Q2 | $281K | Sell |
8,820
-316
| -3% | -$9.96K | 0.32% | 55 |
|
|
2017
Q1 | $297K | Hold |
9,136
| – | – | 0.37% | 52 |
|
|
2016
Q4 | $285K | Hold |
9,136
| – | – | 0.3% | 53 |
|
|
2016
Q3 | $294K | Hold |
9,136
| – | – | 0.38% | 44 |
|
|
2016
Q2 | $305K | Buy |
9,136
+316
| +4% | +$10.1K | 0.4% | 41 |
|
|
2016
Q1 | $248K | Hold |
8,820
| – | – | 0.33% | 53 |
|
|
2015
Q4 | $270K | Hold |
8,820
| – | – | 0.34% | 52 |
|
|
2015
Q3 | $263K | Hold |
8,820
| – | – | 0.34% | 52 |
|
|
2015
Q2 | $281K | Hold |
8,820
| – | – | 0.32% | 58 |
|
|
2015
Q1 | $291K | Hold |
8,820
| – | – | 0.36% | 54 |
|
|
2014
Q4 | $261K | Buy |
+8,820
| New | +$253K | 0.34% | 60 |
|
Other funds holding PFE
VCM
VPM
Cypress Capital Management (Wyoming)'s PFE Position: Q1 2026 in Review
Cypress Capital Management (Wyoming) sold out of Pfizer (PFE) in Q1 2026, closing a stake of 182 shares — an estimated $4.53K sold.
Cypress Capital Management (Wyoming) first reported a position in PFE in Q4 2014 and held it in 38 quarters. The position peaked at $1.3M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Cypress Capital Management (Wyoming) reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Cypress Capital Management (Wyoming) sold 182 Pfizer shares in Q1 2026, an estimated $4.53K.
- Cypress Capital Management (Wyoming) first reported a position in Pfizer in Q4 2014 and held it in 38 quarters.
- Cypress Capital Management (Wyoming)'s Pfizer position peaked at $1.3M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2026, filed 8 May 2026.